Bové, Jordi

Pathogenic Lysosomal Depletion in Parkinson's Disease

Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience

Autophagy in Disease and TherapyParkinson's Disease Mechanisms and Treatments

Cited by 825

Toxin-induced models of Parkinson’s disease

Bové, J., Prou, D., Perier, C., & Przedborski, S. (2005) · NeuroRX

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 739

CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease

Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J. (2020) · Brain

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 267

α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration

Mosharov, E. V., Staal, R. G. W., Bové, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K. E., Moore, C. M. H., Troyer, M. D., et al. (2006) · The Journal of Neuroscience

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 165

BAX channel activity mediates lysosomal disruption linked to Parkinson disease

Bové, J., Martínez-Vicente, M., Dehay, B., Perier, C., Recasens, A., Bombrun, A., Antonsson, B., & Vila, M. (2014) · Autophagy

Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and Therapy

Cited by 89